Publications en collaboration avec des chercheurs de Hospital Virgen de la Arrixaca (35)

2023

  1. Targeting protein methylation in pancreatic cancer cells results in KRAS signaling imbalance and inhibition of autophagy

    Cell Death and Disease, Vol. 14, Núm. 11

2022

  1. Parotid metastasis of clear cell renal carcinoma with simultaneous presence of arterial pseudoaneurysm. Case report and review of literature

    Revista Espanola de Cirugia Oral y Maxilofacial, Vol. 44, Núm. 3, pp. 112-118

2021

  1. Acriflavine, a potent inhibitor of HIF-1α, disturbs glucose metabolism and suppresses ATF4-protective pathways in melanoma under non-hypoxic conditions

    Cancers, Vol. 13, Núm. 1, pp. 1-17

  2. MITF induces escape from innate immunity in melanoma

    Journal of Experimental and Clinical Cancer Research, Vol. 40, Núm. 1

2020

  1. PRMT1-dependent methylation of BRCA1 contributes to the epigenetic defense of breast cancer cells against ionizing radiation

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Evaluation of rat liver with ARFI elastography: In vivo and ex vivo study

    PLoS ONE, Vol. 14, Núm. 5

  2. Mitotic rate as an important prognostic factor in cutaneous malignant melanoma

    Clinical and Translational Oncology, Vol. 21, Núm. 10, pp. 1348-1356

  3. Prognostic value of the Breslow:diameter ratio in cutaneous melanoma

    Journal of the American Academy of Dermatology, Vol. 80, Núm. 3, pp. 806-808

2018

  1. The value of immunohistochemistry using SMARCA4/BRG1 in the diagnosis of small cell ovarian carcinoma hypercalcemic type. A report of two cases

    Revista Espanola de Patologia, Vol. 51, Núm. 1, pp. 61-67

2016

  1. Estudio macro y microscópico de salpingectomías profilácticas en mujeres BRCA positivo

    Revista Espanola de Patologia, Vol. 49, Núm. 2, pp. 81-86

  2. Targeting the epigenetics of the DNA damage response in breast cancer

    Cell Death and Disease, Vol. 7

  3. Tumor suppressor SET9 guides the epigenetic plasticity of breast cancer cells and serves as an early-stage biomarker for predicting metastasis

    Oncogene, Vol. 35, Núm. 47, pp. 6143-6152

2015

  1. Dysregulated cholinergic network as a novel biomarker of poor prognostic in patients with head and neck squamous cell carcinoma

    BMC Cancer, Vol. 15, Núm. 1

  2. Targeting the epigenetic machinery of cancer cells

    Oncogene, Vol. 34, Núm. 2, pp. 135-143

  3. Unbalanced acetylcholinesterase activity in larynx squamous cell carcinoma

    International Immunopharmacology, Vol. 29, Núm. 1, pp. 81-86

2013

  1. Directed Phenotype Switching as an Effective Antimelanoma Strategy

    Cancer Cell, Vol. 24, Núm. 1, pp. 105-119

  2. Suppression of antifolate resistance by targeting the myosin Va trafficking pathway in melanoma

    Neoplasia (United States), Vol. 15, Núm. 7, pp. 826-839

2012

  1. Melanoma coordinates general and cell-specific mechanisms to promote methotrexate resistance

    Experimental Cell Research, Vol. 318, Núm. 10, pp. 1146-1159

  2. Reactivation of the Tumour Suppressor RASSF1A in Breast Cancer by Simultaneous Targeting of DNA and E2F1 Methylation

    PLoS ONE, Vol. 7, Núm. 12

2010

  1. Analysis of cholinesterases in human prostate and sperm. Implications in cancer and fertility

    Chemico-Biological Interactions, Vol. 187, Núm. 1-3, pp. 432-435